Entering text into the input field will update the search result below

Theratechnologies reports Trogarzo results at ACTHIV 2021 meeting

  • Theratechnologies (NASDAQ:THTX) announces results from two posters highlighting positive patient experience with Trogarzo.
  • The poster included findings from 30 Trogarzo (ibalizumab-uiyk) patients to assess real-world patient experience and acceptance of IV administration.
  • The survey found that 100% of patients were either very

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
THTX
--
TH:CA
--